nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefixime—Blood bilirubin increased—Vandetanib—thyroid cancer	0.0315	0.0315	CcSEcCtD
Cefixime—Colitis—Vandetanib—thyroid cancer	0.0286	0.0286	CcSEcCtD
Cefixime—Dermatitis bullous—Vandetanib—thyroid cancer	0.0226	0.0226	CcSEcCtD
Cefixime—Blood bilirubin increased—Sorafenib—thyroid cancer	0.0212	0.0212	CcSEcCtD
Cefixime—Neutropenia—Vandetanib—thyroid cancer	0.0175	0.0175	CcSEcCtD
Cefixime—Hepatic function abnormal—Sorafenib—thyroid cancer	0.0167	0.0167	CcSEcCtD
Cefixime—Stevens-Johnson syndrome—Vandetanib—thyroid cancer	0.0165	0.0165	CcSEcCtD
Cefixime—Renal failure—Vandetanib—thyroid cancer	0.0164	0.0164	CcSEcCtD
Cefixime—Urinary tract infection—Vandetanib—thyroid cancer	0.0162	0.0162	CcSEcCtD
Cefixime—Renal failure acute—Sorafenib—thyroid cancer	0.0158	0.0158	CcSEcCtD
Cefixime—Haemoglobin—Vandetanib—thyroid cancer	0.015	0.015	CcSEcCtD
Cefixime—Haemorrhage—Vandetanib—thyroid cancer	0.0149	0.0149	CcSEcCtD
Cefixime—Lactic dehydrogenase activity increased—Epirubicin—thyroid cancer	0.0145	0.0145	CcSEcCtD
Cefixime—Erythema multiforme—Vandetanib—thyroid cancer	0.0141	0.0141	CcSEcCtD
Cefixime—Lactic dehydrogenase activity increased—Doxorubicin—thyroid cancer	0.0134	0.0134	CcSEcCtD
Cefixime—Toxic epidermal necrolysis—Sorafenib—thyroid cancer	0.0131	0.0131	CcSEcCtD
Cefixime—Blood lactate dehydrogenase increased—Epirubicin—thyroid cancer	0.0128	0.0128	CcSEcCtD
Cefixime—Thrombocytosis—Epirubicin—thyroid cancer	0.0119	0.0119	CcSEcCtD
Cefixime—Blood lactate dehydrogenase increased—Doxorubicin—thyroid cancer	0.0118	0.0118	CcSEcCtD
Cefixime—Neutropenia—Sorafenib—thyroid cancer	0.0118	0.0118	CcSEcCtD
Cefixime—Convulsion—Vandetanib—thyroid cancer	0.0113	0.0113	CcSEcCtD
Cefixime—Stevens-Johnson syndrome—Sorafenib—thyroid cancer	0.0111	0.0111	CcSEcCtD
Cefixime—Thrombocytosis—Doxorubicin—thyroid cancer	0.011	0.011	CcSEcCtD
Cefixime—Renal failure—Sorafenib—thyroid cancer	0.011	0.011	CcSEcCtD
Cefixime—Jaundice—Sorafenib—thyroid cancer	0.0109	0.0109	CcSEcCtD
Cefixime—Thrombocytopenia—Vandetanib—thyroid cancer	0.0104	0.0104	CcSEcCtD
Cefixime—Blister—Epirubicin—thyroid cancer	0.0103	0.0103	CcSEcCtD
Cefixime—Haemoglobin—Sorafenib—thyroid cancer	0.0101	0.0101	CcSEcCtD
Cefixime—Haemorrhage—Sorafenib—thyroid cancer	0.0101	0.0101	CcSEcCtD
Cefixime—Erythema multiforme—Sorafenib—thyroid cancer	0.00953	0.00953	CcSEcCtD
Cefixime—Blister—Doxorubicin—thyroid cancer	0.00952	0.00952	CcSEcCtD
Cefixime—Dyspepsia—Vandetanib—thyroid cancer	0.00935	0.00935	CcSEcCtD
Cefixime—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00868	0.00868	CcSEcCtD
Cefixime—Body temperature increased—Vandetanib—thyroid cancer	0.00839	0.00839	CcSEcCtD
Cefixime—Abdominal pain—Vandetanib—thyroid cancer	0.00839	0.00839	CcSEcCtD
Cefixime—Hyperbilirubinaemia—Epirubicin—thyroid cancer	0.00816	0.00816	CcSEcCtD
Cefixime—Angioedema—Sorafenib—thyroid cancer	0.00802	0.00802	CcSEcCtD
Cefixime—Leukopenia—Sorafenib—thyroid cancer	0.00785	0.00785	CcSEcCtD
Cefixime—Blood bilirubin increased—Epirubicin—thyroid cancer	0.00784	0.00784	CcSEcCtD
Cefixime—Hyperbilirubinaemia—Doxorubicin—thyroid cancer	0.00755	0.00755	CcSEcCtD
Cefixime—Pruritus—Vandetanib—thyroid cancer	0.00751	0.00751	CcSEcCtD
Cefixime—Vaginal inflammation—Epirubicin—thyroid cancer	0.00742	0.00742	CcSEcCtD
Cefixime—Diarrhoea—Vandetanib—thyroid cancer	0.00726	0.00726	CcSEcCtD
Cefixime—Blood bilirubin increased—Doxorubicin—thyroid cancer	0.00726	0.00726	CcSEcCtD
Cefixime—Anaphylactic shock—Sorafenib—thyroid cancer	0.00716	0.00716	CcSEcCtD
Cefixime—Colitis—Epirubicin—thyroid cancer	0.00712	0.00712	CcSEcCtD
Cefixime—Candida infection—Epirubicin—thyroid cancer	0.00708	0.00708	CcSEcCtD
Cefixime—Shock—Sorafenib—thyroid cancer	0.00705	0.00705	CcSEcCtD
Cefixime—Dizziness—Vandetanib—thyroid cancer	0.00702	0.00702	CcSEcCtD
Cefixime—Thrombocytopenia—Sorafenib—thyroid cancer	0.00701	0.00701	CcSEcCtD
Cefixime—Vaginal infection—Epirubicin—thyroid cancer	0.007	0.007	CcSEcCtD
Cefixime—Aplastic anaemia—Epirubicin—thyroid cancer	0.00696	0.00696	CcSEcCtD
Cefixime—Vaginal inflammation—Doxorubicin—thyroid cancer	0.00686	0.00686	CcSEcCtD
Cefixime—Vomiting—Vandetanib—thyroid cancer	0.00675	0.00675	CcSEcCtD
Cefixime—Rash—Vandetanib—thyroid cancer	0.00669	0.00669	CcSEcCtD
Cefixime—Dermatitis—Vandetanib—thyroid cancer	0.00669	0.00669	CcSEcCtD
Cefixime—Headache—Vandetanib—thyroid cancer	0.00665	0.00665	CcSEcCtD
Cefixime—Colitis—Doxorubicin—thyroid cancer	0.00659	0.00659	CcSEcCtD
Cefixime—Candida infection—Doxorubicin—thyroid cancer	0.00655	0.00655	CcSEcCtD
Cefixime—Vaginal infection—Doxorubicin—thyroid cancer	0.00648	0.00648	CcSEcCtD
Cefixime—Aplastic anaemia—Doxorubicin—thyroid cancer	0.00644	0.00644	CcSEcCtD
Cefixime—Nausea—Vandetanib—thyroid cancer	0.00631	0.00631	CcSEcCtD
Cefixime—Dyspepsia—Sorafenib—thyroid cancer	0.0063	0.0063	CcSEcCtD
Cefixime—Hepatic function abnormal—Epirubicin—thyroid cancer	0.00616	0.00616	CcSEcCtD
Cefixime—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00586	0.00586	CcSEcCtD
Cefixime—Renal failure acute—Epirubicin—thyroid cancer	0.00583	0.00583	CcSEcCtD
Cefixime—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.0057	0.0057	CcSEcCtD
Cefixime—Urticaria—Sorafenib—thyroid cancer	0.00569	0.00569	CcSEcCtD
Cefixime—Abdominal pain—Sorafenib—thyroid cancer	0.00566	0.00566	CcSEcCtD
Cefixime—Body temperature increased—Sorafenib—thyroid cancer	0.00566	0.00566	CcSEcCtD
Cefixime—Renal impairment—Epirubicin—thyroid cancer	0.00566	0.00566	CcSEcCtD
Cefixime—Dermatitis bullous—Epirubicin—thyroid cancer	0.00563	0.00563	CcSEcCtD
Cefixime—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.00556	0.00556	CcSEcCtD
Cefixime—Renal failure acute—Doxorubicin—thyroid cancer	0.0054	0.0054	CcSEcCtD
Cefixime—Hypersensitivity—Sorafenib—thyroid cancer	0.00528	0.00528	CcSEcCtD
Cefixime—Renal impairment—Doxorubicin—thyroid cancer	0.00524	0.00524	CcSEcCtD
Cefixime—Dermatitis bullous—Doxorubicin—thyroid cancer	0.00521	0.00521	CcSEcCtD
Cefixime—Face oedema—Epirubicin—thyroid cancer	0.0052	0.0052	CcSEcCtD
Cefixime—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.00515	0.00515	CcSEcCtD
Cefixime—Pruritus—Sorafenib—thyroid cancer	0.00507	0.00507	CcSEcCtD
Cefixime—Diarrhoea—Sorafenib—thyroid cancer	0.0049	0.0049	CcSEcCtD
Cefixime—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.00485	0.00485	CcSEcCtD
Cefixime—Face oedema—Doxorubicin—thyroid cancer	0.00481	0.00481	CcSEcCtD
Cefixime—Dizziness—Sorafenib—thyroid cancer	0.00474	0.00474	CcSEcCtD
Cefixime—Eosinophilia—Epirubicin—thyroid cancer	0.00461	0.00461	CcSEcCtD
Cefixime—Vomiting—Sorafenib—thyroid cancer	0.00455	0.00455	CcSEcCtD
Cefixime—Rash—Sorafenib—thyroid cancer	0.00452	0.00452	CcSEcCtD
Cefixime—Dermatitis—Sorafenib—thyroid cancer	0.00451	0.00451	CcSEcCtD
Cefixime—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.00449	0.00449	CcSEcCtD
Cefixime—Headache—Sorafenib—thyroid cancer	0.00449	0.00449	CcSEcCtD
Cefixime—Pancytopenia—Epirubicin—thyroid cancer	0.00442	0.00442	CcSEcCtD
Cefixime—Neutropenia—Epirubicin—thyroid cancer	0.00435	0.00435	CcSEcCtD
Cefixime—Eosinophilia—Doxorubicin—thyroid cancer	0.00426	0.00426	CcSEcCtD
Cefixime—Nausea—Sorafenib—thyroid cancer	0.00425	0.00425	CcSEcCtD
Cefixime—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.00411	0.00411	CcSEcCtD
Cefixime—Pancytopenia—Doxorubicin—thyroid cancer	0.00409	0.00409	CcSEcCtD
Cefixime—Renal failure—Epirubicin—thyroid cancer	0.00408	0.00408	CcSEcCtD
Cefixime—Jaundice—Epirubicin—thyroid cancer	0.00404	0.00404	CcSEcCtD
Cefixime—Urinary tract infection—Epirubicin—thyroid cancer	0.00403	0.00403	CcSEcCtD
Cefixime—Neutropenia—Doxorubicin—thyroid cancer	0.00403	0.00403	CcSEcCtD
Cefixime—Agranulocytosis—Epirubicin—thyroid cancer	0.00387	0.00387	CcSEcCtD
Cefixime—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.00381	0.00381	CcSEcCtD
Cefixime—Renal failure—Doxorubicin—thyroid cancer	0.00377	0.00377	CcSEcCtD
Cefixime—Haemoglobin—Epirubicin—thyroid cancer	0.00374	0.00374	CcSEcCtD
Cefixime—Jaundice—Doxorubicin—thyroid cancer	0.00374	0.00374	CcSEcCtD
Cefixime—Urinary tract infection—Doxorubicin—thyroid cancer	0.00373	0.00373	CcSEcCtD
Cefixime—Haemorrhage—Epirubicin—thyroid cancer	0.00373	0.00373	CcSEcCtD
Cefixime—Hepatitis—Epirubicin—thyroid cancer	0.00373	0.00373	CcSEcCtD
Cefixime—Agranulocytosis—Doxorubicin—thyroid cancer	0.00358	0.00358	CcSEcCtD
Cefixime—Erythema multiforme—Epirubicin—thyroid cancer	0.00352	0.00352	CcSEcCtD
Cefixime—Haemoglobin—Doxorubicin—thyroid cancer	0.00346	0.00346	CcSEcCtD
Cefixime—Haemorrhage—Doxorubicin—thyroid cancer	0.00345	0.00345	CcSEcCtD
Cefixime—Hepatitis—Doxorubicin—thyroid cancer	0.00345	0.00345	CcSEcCtD
Cefixime—Erythema multiforme—Doxorubicin—thyroid cancer	0.00326	0.00326	CcSEcCtD
Cefixime—Flatulence—Epirubicin—thyroid cancer	0.0032	0.0032	CcSEcCtD
Cefixime—Flatulence—Doxorubicin—thyroid cancer	0.00296	0.00296	CcSEcCtD
Cefixime—Leukopenia—Epirubicin—thyroid cancer	0.0029	0.0029	CcSEcCtD
Cefixime—Convulsion—Epirubicin—thyroid cancer	0.00281	0.00281	CcSEcCtD
Cefixime—Leukopenia—Doxorubicin—thyroid cancer	0.00269	0.00269	CcSEcCtD
Cefixime—Anaphylactic shock—Epirubicin—thyroid cancer	0.00265	0.00265	CcSEcCtD
Cefixime—Shock—Epirubicin—thyroid cancer	0.0026	0.0026	CcSEcCtD
Cefixime—Convulsion—Doxorubicin—thyroid cancer	0.0026	0.0026	CcSEcCtD
Cefixime—Thrombocytopenia—Epirubicin—thyroid cancer	0.00259	0.00259	CcSEcCtD
Cefixime—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00245	0.00245	CcSEcCtD
Cefixime—Shock—Doxorubicin—thyroid cancer	0.00241	0.00241	CcSEcCtD
Cefixime—Thrombocytopenia—Doxorubicin—thyroid cancer	0.0024	0.0024	CcSEcCtD
Cefixime—Dyspepsia—Epirubicin—thyroid cancer	0.00233	0.00233	CcSEcCtD
Cefixime—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00216	0.00216	CcSEcCtD
Cefixime—Dyspepsia—Doxorubicin—thyroid cancer	0.00216	0.00216	CcSEcCtD
Cefixime—Urticaria—Epirubicin—thyroid cancer	0.0021	0.0021	CcSEcCtD
Cefixime—Body temperature increased—Epirubicin—thyroid cancer	0.00209	0.00209	CcSEcCtD
Cefixime—Abdominal pain—Epirubicin—thyroid cancer	0.00209	0.00209	CcSEcCtD
Cefixime—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.002	0.002	CcSEcCtD
Cefixime—Hypersensitivity—Epirubicin—thyroid cancer	0.00195	0.00195	CcSEcCtD
Cefixime—Urticaria—Doxorubicin—thyroid cancer	0.00195	0.00195	CcSEcCtD
Cefixime—Body temperature increased—Doxorubicin—thyroid cancer	0.00194	0.00194	CcSEcCtD
Cefixime—Abdominal pain—Doxorubicin—thyroid cancer	0.00194	0.00194	CcSEcCtD
Cefixime—Pruritus—Epirubicin—thyroid cancer	0.00187	0.00187	CcSEcCtD
Cefixime—Diarrhoea—Epirubicin—thyroid cancer	0.00181	0.00181	CcSEcCtD
Cefixime—Hypersensitivity—Doxorubicin—thyroid cancer	0.0018	0.0018	CcSEcCtD
Cefixime—Dizziness—Epirubicin—thyroid cancer	0.00175	0.00175	CcSEcCtD
Cefixime—Pruritus—Doxorubicin—thyroid cancer	0.00173	0.00173	CcSEcCtD
Cefixime—Vomiting—Epirubicin—thyroid cancer	0.00168	0.00168	CcSEcCtD
Cefixime—Diarrhoea—Doxorubicin—thyroid cancer	0.00168	0.00168	CcSEcCtD
Cefixime—Rash—Epirubicin—thyroid cancer	0.00167	0.00167	CcSEcCtD
Cefixime—Dermatitis—Epirubicin—thyroid cancer	0.00167	0.00167	CcSEcCtD
Cefixime—Headache—Epirubicin—thyroid cancer	0.00166	0.00166	CcSEcCtD
Cefixime—Dizziness—Doxorubicin—thyroid cancer	0.00162	0.00162	CcSEcCtD
Cefixime—Nausea—Epirubicin—thyroid cancer	0.00157	0.00157	CcSEcCtD
Cefixime—Vomiting—Doxorubicin—thyroid cancer	0.00156	0.00156	CcSEcCtD
Cefixime—Rash—Doxorubicin—thyroid cancer	0.00154	0.00154	CcSEcCtD
Cefixime—Dermatitis—Doxorubicin—thyroid cancer	0.00154	0.00154	CcSEcCtD
Cefixime—Headache—Doxorubicin—thyroid cancer	0.00153	0.00153	CcSEcCtD
Cefixime—Nausea—Doxorubicin—thyroid cancer	0.00145	0.00145	CcSEcCtD
